Steven Paul Insider Profile

11 Followers
Steven Paul, Director at SAGE Therapeutics, holds 593.11K shares in SAGE Therapeutics (Ticker: SAGE), holds ― shares in Voyager Therapeutics (Ticker: VYGR), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX).
tipranks
Steven Paul

Steven Paul
SAGE Therapeutics (SAGE)
Director

Ranked #1,572 out of 99,218 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+130.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$69M
94.16%
5.44%
0.40%
0.00%
A breakdown of Steven Paul's holdings

Insider Roles

Eli Lilly & Co
(LLY)
EVP, Science and Technology
SAGE Therapeutics
(SAGE)
Director
Alnylam Pharma
(ALNY)
Director
Voyager Therapeutics
(VYGR)
Director
Roles that Steven Paul holds in companies

Most Profitable Insider Trade

Stock:
Karuna Therapeutics
(KRTX)
Rating:Informative Buy
Date:Jul 01, 2019 - Jul 01, 2020
Return:+406.90%
The most profitable trade made by Steven Paul

Steven Paul's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SAGE Therapeutics
Nov 30, 2022
Director
Uninformative Buy
190.80
$3.74M
Voyager Therapeutics
Director
KRTX
Karuna Therapeutics
Mar 18, 2024
Uninformative Sell
49.82M
$0.00
Alnylam Pharma
Apr 05, 2022
Director
Uninformative Buy
169.95K
$277.43K
SIAL
Sigma-Aldrich Corp
Nov 19, 2015
Uninformative Sell
66.92K
Eli Lilly & Co
Feb 03, 2010
EVP, Science and Technology
Uninformative Buy
610.79K
$64.81M
List of latest transactions for each holding click on a transaction to see Steven Paul's performance on stock

Steven Paul insider profile FAQ

What is the percentage of profitable transactions made by Steven Paul?
The percentage of profitable transactions made by Steven Paul is 80%.
    What is the average return per transaction made by Steven Paul?
    The average return per transaction made by Steven Paul is 130.60%.
      What stocks does Steven Paul hold?
      Steven Paul holds: SAGE, VYGR, KRTX, ALNY, SIAL, LLY stocks.
        What was Steven Paul’s latest transaction?
        Steven Paul latest transaction was an Uninformative Buy of $190.80.
          What was Steven Paul's most profitable transaction?
          Steven Paul’s most profitable transaction was an Informative Buy of KRTX stock on July 1, 2019. The return on the trade was 406.90%.
            What is Steven Paul's role in SAGE Therapeutics?
            Steven Paul's role in SAGE Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.